Arch Therapeutics CEO looks ahead to positive results on AC5 gel

Arch Therapeutics (OTCMKTS:ARTH, OTCQB:ARTH) CEO Dr. Terry Norchie tells Proactive Investors the biotechnology company is …
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
526